Sickle cell hepatopathy


Sickle cell hepatopathy

Description, Causes and Risk Factors:

Sickle cell hepatopathy encompasses a range of hepatic pathology arising from a wide variety of insults to the liver in patients with sickle cell disease. It occurs predominantly in patients with homozygous sickle cell anemia, and to a lesser extent in patients with sickle cell trait, HbSC disease and HbS/ß-Thalassemia. The hepatic disease may primarily be caused by the sickling process, but more commonly arises as a consequence of the multiple transfusions that these patients require in their lifetime. The term multitransfusion hepatopathy may therefore be more appropriate for these latter patients.

The main hepatic complications of multiple transfusions include acute and chronic infection with hepatitis B and C and iron overload. A further potential consequence of the chronic hemolysis is the development of pigment stones, with consequent cholecystitis and acute and chronic biliary obstruction from choledocholithiasis.

Unfortunately, much of the literature on sickle cell hepatopathy lacks depth, because there are few sizeable or controlled studies, and most studies provide only incomplete information regarding coexisting chronic infection with hepatitis B or C, hepatic iron deposition, and chronic biliary obstruction from choledocholithiasis. It is therefore difficult to evaluate the contributing effects of these various insults in the final pathologic and clinical picture in these patients. As will be discussed subsequently, sickle cell anemia may lead to several unique liver syndromes.

Furthermore but less common, hepatic injury can be directly related to the sickling process and hence the term most often used to describe these syndromes is sickle cell hepatopathy e.g., acute hepatic crisis and hepatic sequestration crisis. Sickle cell intrahepatic cholestasis is a rare form of sickle cell hepatopathy. It is potentially fatal with a poor prognosis. Therefore, early identification is essential. It is thought to represent a severe form of hepatic crisis.

Symptoms:

Symptoms may include:

    RUQ (right upper quadrant) abdominal pain.

  • Jaundice.

  • Nausea.

  • Low-grade fever.

Signs may include:

    Hepatomegaly.

  • AST (aspartate aminotransferase) and ALT (alanine aminotransferase) rarely exceed 300 IU/L.

  • Serum bilirubin levels usually less than 15 mg/dL.

Diagnosis:

Differential diagnosis may include: sickle cell intrahepatic cholestasis, acute viral hepatitis, cholecystitis, and choledocholithiasis with common bile duct obstruction.

Diagnostic Imaging

    Ultrasound: Bile gallstones, increased echogenicity due to iron deposition.

  • Computerized Tomography: Diffuse hepatomegaly.

  • Magnetic Resonance Imaging: Transfusion dependent patients usually show decreased signal intensity in the liver, pancreas, and spleen due to iron deposition.

  • Biliary scintigraphy.

  • Liver & spleen scan.

Liver biopsy is important in establishing the correct diagnosis and in instituting appropriate management, though it should be borne in mind that the patient may have another distinct liver disease co-existing with sickle-cell disease.

Treatment:

sickle cell hepatopathy

Treatment Options:

The goals of treating sickle cell hepatopathy are to relieve pain; prevent infections, eye damage, and strokes; and control complications if they occur. The treatments include medicine, blood transfusions, and specific treatment for complications.

    Abnormal LFTs and bilirubin are coming in sickle cell hepatopathy.

  • Do not forget to look for liver injury.

  • Rule out other common causes of acute liver injury.

  • Distinguish between acute syndrome and chronic multitransfusion hepatopathy.

  • Do not transfuse unless necessary and if so, do exchange.

  • Be aware of zinc deficiency.

  • Avoid hepatotoxic drugs.

Some researchers believe that bone marrow transplants may offer a cure in a small number of cases. Researchers are looking for new treatments for sickle cell hepatopathy, including gene therapy and safer and more effective bone marrow transplants.

NOTE: The above information is educational purpose. The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition.

DISCLAIMER: This information should not substitute for seeking responsible, professional medical care.

0 Comments

Submit a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Cart Preview

A Hot Bath Can Reduce Inflammation and Improve Glucose Metabolism

A Hot Bath Can Reduce Inflammation and Improve Glucose Metabolism

A new study, published in the Journal of Applied Psychology, finds that a hot bath may help reduce inflammation and improve metabolism. As a part of an experiment, each study participant took a hot bath with water temperature 102°F (39°C) for one hour. The researchers...

[WpProQuiz 1]

Featured Products

The 5 Best Accessories for Sports Fans

It is very entertaining to be a sport fan. There is a big variety of sport games that are extremely interesting to follow. Moreover, it is always fun to anticipate the score and watch the enthusiasm live. One of the benefits of being sports fan is using different...

read more

Exercise May Serve as an Antidepressant

A new study of nearly 18,000 participants found that those with high fitness at middle age were significantly less likely to die from heart disease in later life, even if they were diagnosed with depression. Doctor's Tips: How to Stay Fit While Treating Depression Dr....

read more

MediGoo is attending the largest health/medical industry event in Düsseford, Germany. We welcome you to visit our stand at hall 15 booth E55. Welcome, hope to see you there 15E55.